These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 14774030)

  • 1. Studies on rickettsial toxin simplified potency-test of typhus vaccine in mice by direct challenge of the toxin.
    KITAOKA M; SHISHIDO A
    Jpn Med J (Natl Inst Health Jpn); 1950 Feb; 3(1):1-10. PubMed ID: 14774030
    [No Abstract]   [Full Text] [Related]  

  • 2. The constitution of that rickettsia and soluble rickettsial antigen derived from the epidemic typhus vaccine.
    COHEN SS
    Fed Proc; 1946; 5(1 Pt 2):129. PubMed ID: 21066650
    [No Abstract]   [Full Text] [Related]  

  • 3. Studies on commercial typhus vaccines. III. The concentration and isolation of the Rickettsia-specific soluble antigen of commercial typhus vaccine.
    COHEN SS; CHAMBERS LA; CLAWSON JR
    J Immunol; 1950 Nov; 65(5):465-73. PubMed ID: 14794910
    [No Abstract]   [Full Text] [Related]  

  • 4. Studies on commercial typhus vaccines. IV. The chemical composition of the antigens of commercial typhus vaccine.
    COHEN SS
    J Immunol; 1950 Nov; 65(5):475-83. PubMed ID: 14794911
    [No Abstract]   [Full Text] [Related]  

  • 5. Studies on commercial typhus vaccines. II. The antigenic fractions of disrupted epidemic typhus rickettsiae.
    CHAMBERS LA; COHEN SS; CLAWSON JR
    J Immunol; 1950 Nov; 65(5):459-63. PubMed ID: 14794909
    [No Abstract]   [Full Text] [Related]  

  • 6. The effect of typhus vaccine on the numbers of rickettsiae in body lice of typhus patients.
    SNYDER JC; MURRAY ES
    Am J Hyg; 1949 May; 49(3):340-5. PubMed ID: 18126463
    [No Abstract]   [Full Text] [Related]  

  • 7. An experimental study on a derivative of Laigret-Durand's strain of murine rickettsiae for the preparation of living typhus vaccine; isolation of ectromelia virus from the vaccine strain.
    PACKALEN T
    Acta Pathol Microbiol Scand; 1947; 24(3-4):375-8. PubMed ID: 18900905
    [No Abstract]   [Full Text] [Related]  

  • 8. An experimental study on a derivative of Laigret-Durand's strain of murine rickettsiae for the preparation of living typhus vaccine; serological and immunological analysis.
    KLING C; PACKALEN T
    Acta Pathol Microbiol Scand; 1947; 24(3-4):371-4. PubMed ID: 18900904
    [No Abstract]   [Full Text] [Related]  

  • 9. The standardisation of a scrub typhus vaccine.
    HENDERSON-BEGG A; FULTON F
    J Pathol Bacteriol; 1946 Jul; 58(3):381-9. PubMed ID: 20283074
    [No Abstract]   [Full Text] [Related]  

  • 10. LIVE TYPHUS VACCINE PREPARED FROM STRAIN "E" OF RICKETTSIA PROWAZEKI.
    GOLINEVICH EM; YABLONSKAYA VA
    J Hyg Epidemiol Microbiol Immunol; 1963; 7():290-300. PubMed ID: 14113553
    [No Abstract]   [Full Text] [Related]  

  • 11. [On biological characteristics of vaccinal strain E of Rickettsia prowazekii (observations on the immunization of humans with live typhus vaccine)].
    PSHENICHNOV VA; LEVASHOV AA; NIKOLENKO VIa
    Vopr Virusol; 1959; 4():698-703. PubMed ID: 14435201
    [No Abstract]   [Full Text] [Related]  

  • 12. Rickettsial vaccines with emphasis on epidemic typhus. Initial report of an old vaccine trial.
    Woodward TE
    S Afr Med J; 1986 Oct; Suppl():73-6. PubMed ID: 3095934
    [No Abstract]   [Full Text] [Related]  

  • 13. A method for increasing the infectivity of yolk-sac cultures of the rickettsiae of epidemic and murine typhus, and South African tick-bite fever.
    BERKOWITZ AP
    S Afr J Med Sci; 1946 Nov; 11(2-3):69-72. PubMed ID: 20282007
    [No Abstract]   [Full Text] [Related]  

  • 14. [DATA ON THE IMMUNIZATION OF MAN WITH LIVE TYPHUS VACCINE FROM THE E STRAIN].
    URAKOV NN; PSHENICHNOV VA; SHCHETININ VP; TERESHCHENKO MO
    Zh Mikrobiol Epidemiol Immunobiol; 1963 Jul; 40():40-5. PubMed ID: 14070202
    [No Abstract]   [Full Text] [Related]  

  • 15. A reference, inactivated, epidemic typhus vaccine: clinical trials in man.
    Mason RA; Wenzel RP; Seligmann EB; Ginn RK
    J Biol Stand; 1976; 4(3):217-24. PubMed ID: 820697
    [No Abstract]   [Full Text] [Related]  

  • 16. Methods of evaluation of typhus vaccine potency.
    MOSING H
    Med Dent Bull; 1947 Nov; 19(11):104. PubMed ID: 20270896
    [No Abstract]   [Full Text] [Related]  

  • 17. Methods of evaluation of typhus vaccine potency.
    MOSING H
    Tex Rep Biol Med; 1947; 5(2):173-6. PubMed ID: 20255935
    [No Abstract]   [Full Text] [Related]  

  • 18. Studies on commercial typhus vaccines. I. The antigenic constituents of commercial epidemic typhus vaccine.
    CHAMBERS LA; CLAWSON JR
    J Immunol; 1950 Nov; 65(5):451-7. PubMed ID: 14794908
    [No Abstract]   [Full Text] [Related]  

  • 19. On increasing the yield and potency of typhus vaccine prepared from infected yolk sacs.
    GROUPE V; NIGG C; MACFARLANE JO
    J Immunol; 1946 Aug; 53():303-14. PubMed ID: 20998814
    [No Abstract]   [Full Text] [Related]  

  • 20. Typhus at Belsen. II. Clinical course of epidemic typhus in persons who had received Craigie typhus vaccine.
    DAVIS WA
    Ann Intern Med; 1951 Feb; 34(2):448-65. PubMed ID: 14800216
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.